Copy to clipboard 
Bob Kramer, President and CEO of Microcision LLC, has purchased the majority equity interest in the company from his long-time financial partners.
Microcision specializes in the design, development, launch and replenishment of medical device implants and instruments for the orthopedic industry’s most technologically advanced OEMs.
Kramer explains, “Our customers are producing incredibly advanced designs for the implant market. Microcision’s focus expands every year to specialize in the most difficult to produce products and assemblies. Our move into a state-of-the-art, new facility three years ago has also allowed the company to substantially grow. It’s an awesome outcome that my previous partners and I were able to complete this transaction for the benefit of everyone, especially for the future health and growth of this 70-year-old company.”
Two of Microcison’s previous partners, Bryant Prentice III and Rand Capital, will remain as minority investors.
